Clinical Trials Insight: 700014188
Phase of Trial: Phase III
Latest Information Update: 20 May 2009
At a glance
- Drugs Doxepin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Somaxon Pharmaceuticals
- 20 May 2009 Results presented at the 162nd Annual Meeting of the American Psychiatric Association (APA 2009).
- 08 May 2008 Results were presented at the American Psychiatric Association 161st annual meeting according to a Somaxon Pharmaceuticals media release.
- 07 May 2008 Results data have been reported in a Somaxon media release.